Hypertension due to liquorice and liquorice tea consumption;Hypertensie door consumptie van drop en zoethoutthee

Nederlands Tijdschrift voor Geneeskunde

Volumn 151, Issue 51, 2007, Pages 2825-2828

  Boganen, H ^a   Van Hee, K ^a   Grundmeijer, H G L M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID;

ARTICLE; GLYCYRRHIZA; HUMAN; HYPERTENSION; NETHERLANDS; PRACTICE GUIDELINE; PUBLICATION; TEA;

BEVERAGES; FOOD-DRUG INTERACTIONS; GLYCYRRHIZA; HUMANS; HYPERTENSION; TEA;

EID: 37549003688     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Brouwers AJBW, Meulen J van der. 'Drophypertensie'; ook door zoethoutthee. Ned Tijdschr Geneeskd. 2001;145:744-7.
2. Ploeger B, Mensinga T, Sips A, Deerenberg C, Meulenbelt J, DeJongh J. A population physiologically based pharmacokinetic/pharmacodynamic model for the inhibition of 11 beta-hydroxysteroid dehydrogenase activity by glycyrrhetic acid. Toxicol Appl Pharmacol. 2001;170:46-55.
3. Krähenbühl S, Hasler F, Frey BM, Frey FJ, Brenneisen R, Krapf R. Kinetics and dynamics of orally 18 beta-glycyrrhetinic acid in humans. J Clin Endocrinol Metab. 1994;78:581-5.
4. Ferrari P, Lovati E, Frey FJ. The role of the 11 beta-hydroxysteroid dehydrogenase type 2 in human hypertension. J Hypertens. 2000;18:241-8.
5. Bowmer CJ, Yates MS. Drugs and the renal system. In: Crowe L, editor. Integrated pharmacology. Edinburgh: Mosby; 2002. p. 343-60.
6. Uum SH van. Liquorice and hypertension. Neth J Med. 2005;63:119-20.
7. Cutler JA, Follmann D, Allender PS. Randomized trials of sodium reduction: an overview. Am J Clin Nutr. 1997;65(2 Suppl):P643S-51S.
8. Sigurjonsdottir HA, Manhem K, Axelson M, Wallerstedt S. Subjects with essential hypertension are more sensitive to the inhibition of 11 beta-HSD by liquorice. J Hum Hypertens. 2003;17:125-31.
9. Sigurjonsdottir HA, Franzson L, Manhem K, Ragnarsson J, Sigurdsson G, Wallerstedt S. Liquorice-induced rise in blood pressure: a linear dose-response relationship. J Hum Hypertens. 2001;15:549-52.
10. Ferrari P, Sansonnens A, Dick B, Frey FJ. In vivo 11 beta-HSD-2 activity: variability, salt sensitivity and effect of licorice. Hypertension. 2001;38:1330-6.
11. Gelderen CEM van, Bijlsma JA, Dokkum W van, Savelkoul TJ. Glycyrrhizic acid: the assessment of a no effect level. Hum Exp Toxicol. 2000;19:434-9.
12. Bernardi M, D'Intino PE, Trevisani F, Cantelli-Forti G, Raggi MA, Turchetto E, et al. Effects of prolonged ingestion of graded doses of licorice by healthy volunteers. Life Sci. 1994;55:863-72.
13. MacKenzie MA, Hoefnagels WH, Jansen RW, Benraad TJ, Kloppenborg PW. The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers. J Clin Endocrinol Metab. 1990;70:1637-43.
14. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. Mineralocorticoid activity of liquorice: 11 beta-hydroxysteroid dehydrogenase deficiency comes ofage. Lancet. 1987;2(8563):821-4.
15. Heikens J, Fliers E, Endert E, Ackermans M, Montfrans G van. Liquorice-induced hypertension - a new understanding of an old disease: case report and brief review. Neth J Med. 1995;47:230-4.
16. Störmer FC, Reistad R, Alexander J. Glycyrrhizic acid in liquorice-evaluation of health hazard. Food Chem Toxicol. 1993;31:303-12.